Global Drug Discovery Informatics Market Size & Outlook
Global drug discovery informatics market, 2018-2030 (US$M)
Related Markets
Global drug discovery informatics market highlights
- The global drug discovery informatics market generated a revenue of USD 3,650.0 million in 2024 and is expected to reach USD 7,030.0 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 11.6% by 2030.
- In terms of segment, sequence analysis platforms accounted for a revenue of USD 1,492.7 million in 2024.
- Sequence Analysis Platforms is the most lucrative service segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 3,650.0 million |
| Market revenue in 2030 | USD 7,030.0 million |
| Growth rate | 11.6% (CAGR from 2025 to 2030) |
| Largest segment | Sequence analysis platforms |
| Fastest growing segment | Sequence Analysis Platforms |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management |
Other key industry trends
- In terms of revenue, the North America accounted for 40.9% of the global drug discovery informatics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 749.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Informatics Market Scope
Drug Discovery Informatics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Albany Molecular Research | View profile | 1001-5000 | Albany, New York, United States, North America | http://amriglobal.com |
| ChemAxon | View profile | 101-250 | Utica, New York, United States, North America | https://chemaxon.com/company |
| Selvita | View profile | 501-1000 | Sedziszow Malopolski, Podkarpackie, Poland, Europe | http://www.selvita.com/ |
| Jubilant Biosys | View profile | 501-1000 | Bengaluru, Karnataka, India, Asia | https://www.jubilantbiosys.com/ |
| Certara Inc Ordinary Shares | View profile | 1391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | https://www.certara.com |
| Infosys Ltd ADR | View profile | 322663 | 44, Infosys Avenue, Hosur Road, Electronics City, Bengaluru, KA, India, 560 100 | https://www.infosys.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Accenture PLC Class A | View profile | 742000 | 1 Grand Canal Square, Grand Canal Harbour, Dublin, Ireland, 2 | https://www.accenture.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Oracle Corp | View profile | 164000 | 2300 Oracle Way, Austin, TX, United States, 78741 | https://www.oracle.com |
Global drug discovery informatics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Sequence analysis platforms was the largest segment with a revenue share of 40.9% in 2024. Horizon Databook has segmented the Global drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Drug Discovery Informatics Service Outlook (Revenue, USD Million, 2018-2030)
- Sequence Analysis Platforms
- Docking
- Molecular Modelling
- Clinical Trial Data Management
- Others
- Global Drug Discovery Informatics Application Outlook (Revenue, USD Million, 2018-2030)
- Biocontent Management
- Discovery Informatics
- Global Drug Discovery Informatics End Use Outlook (Revenue, USD Million, 2018-2030)
- CROs & CMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Reasons to subscribe to Global drug discovery informatics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global drug discovery informatics market databook
-
Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global drug discovery informatics market , including forecasts for subscribers. This global databook contains high-level insights into Global drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global drug discovery informatics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Drug discovery informatics market size, 2024 (US$M)
Global drug discovery informatics market share, by end use, 2024 & 2030 (%, US$M)
Drug discovery informatics market: Opportunity assessment by country
Global drug discovery informatics market, by region, 2024 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
